Baxter Bros Inc Nuvectis Pharma, Inc. Transaction History
Baxter Bros Inc
- $756 Million
- Q4 2024
A detailed history of Baxter Bros Inc transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Baxter Bros Inc holds 15,000 shares of NVCT stock, worth $113,700. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,000
Previous 12,500
20.0%
Holding current value
$113,700
Previous $78,000
3.85%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding NVCT
# of Institutions
32Shares Held
1.9MCall Options Held
0Put Options Held
0-
Ronit Capital LLP563KShares$4.26 Million5.37% of portfolio
-
Baldwin Brothers LLC356KShares$2.7 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA325KShares$2.47 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0125KShares$944,2480.0% of portfolio
-
Black Rock Inc. New York, NY83.4KShares$632,2620.0% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $111M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...